Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
2.
Annales Francaises d'Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale ; 2020.
Article in French | Scopus | ID: covidwho-827412
3.
Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale ; 2020.
Article in French | PMC | ID: covidwho-822575
4.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(4): 315-317, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-502486

ABSTRACT

This consensus statement about the indications and modalities of corticosteroid treatment in the context of the COVID-19 pandemic was jointly written by experts from the French Association of Otology and Oto-Neurology (AFON) and from the French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL). There is currently not enough data in favour of danger or benefit from corticosteroids in COVID-19, so until this matter is resolved it is advisable to limit their indications to the most serious clinical pictures for which it is well established that this type of treatment has a positive impact on the progression of symptoms. In Grade V and VI Bell's palsy according to the House-Brackmann grading system, a week's course of oral corticosteroids is recommended. Corticosteroid therapy is also recommended in cases of sudden hearing loss of more than 60dB, either in the form of intratympanic injections or a week's course of oral medication. In rhinology, there is no indication for systemic corticosteroid therapy in the current situation. However, patients are advised to continue with their local corticosteroid therapy in the form of a nasal spray or by inhalation. Treatments with corticosteroid nasal sprays can still be prescribed if there is no alternative. Finally, systemic or local corticosteroid therapy is not indicated for bacterial ENT infections.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Coronavirus Infections/drug therapy , Otorhinolaryngologic Diseases/drug therapy , Pneumonia, Viral/drug therapy , COVID-19 , Coronavirus Infections/complications , Humans , Otorhinolaryngologic Diseases/virology , Pandemics , Pneumonia, Viral/complications
5.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(4): 323-324, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-401254

ABSTRACT

Based on a review of the medical literature, the authors document the key points regarding the tests available in France to screen for and diagnose of CoV-2 infestation.


Subject(s)
Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , COVID-19 , COVID-19 Testing , France , Humans , Pandemics
6.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(4): 309-314, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-229878

ABSTRACT

The purpose of this article is to give rhinologists advice on how to adapt their standard practice during the COVID-19 pandemic. The main goal of these recommendations is to protect healthcare workers against COVID-19 while continuing to provide emergency care so as to prevent loss of chance for patients. We reviewed our recommendations concerning consultations, medical prescriptions and surgical activity in rhinology.


Subject(s)
Coronavirus Infections/prevention & control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Otorhinolaryngologic Diseases , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , Coronavirus Infections/transmission , Decision Trees , Humans , Operating Rooms , Otolaryngology/standards , Otorhinolaryngologic Diseases/diagnosis , Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures , Pneumonia, Viral/transmission , Practice Guidelines as Topic
7.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(3): 161-166, 2020 May.
Article in English | MEDLINE | ID: covidwho-108790

ABSTRACT

In Otorhinolaryngology - Head and Neck Surgery, clinical examination and invasive procedures on the respiratory tract and on airway-connected cavities, such as paranasal sinuses and the middle ear, expose people to direct transmission of SARS-CoV-2 by inhalation or ocular projection of contaminated droplets, and to indirect transmission by contact with contaminated hands, objects or surfaces. Estimating an R0 of COVID-19 at around 3 justified postponing non-urgent face-to-face consultations and expanding the use of teleconsultation in order to limit the risks of SARS-CoV-2 infection of patients or health workers and comply with the lockdown. The health authority recommends cancellation of all medical or surgical activities, which are not urgent as long as this does not involve a loss of chance for the patient. The purpose of this cancellation is to significantly increase critical care capacity, prioritise the reception of patients with COVID-19, prioritise the allocation of staff and provision of the equipment necessary for their medical or surgical management, and contribute to the smooth running of downstream critical care within their establishment. Another goal is to reduce the risks of patient contamination within healthcare facilities. This document provides guidance on how to proceed with and adapt ENT surgery in the current pandemic context, as well as on the management of postponed operations. This best practice advice must of course be adapted in each region according to the development of the epidemic and pre-existing arrangements. Their local application can only be decided within the framework of collaboration between the ENT teams, the operational hygiene units and all the other specialties concerned.


Subject(s)
Coronavirus Infections/prevention & control , Otorhinolaryngologic Surgical Procedures/methods , Otorhinolaryngologic Surgical Procedures/standards , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , France/epidemiology , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/surgery , Head and Neck Neoplasms/virology , Humans , Infection Control/methods , Infection Control/standards , Otolaryngology/methods , Otolaryngology/standards , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , SARS-CoV-2
8.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(3): 167-169, 2020 May.
Article in English | MEDLINE | ID: covidwho-99339

ABSTRACT

Tracheostomy post-tracheostomy care are regarded as at high risk for contamination of health care professionals with the new coronavirus (SARS-CoV-2). Considering the rapid spread of the infection, all patients in France must be considered as potentially infected by the virus. Nevertheless, patients without clinical or radiological (CT scan) markers of COVID-19, and with negative nasopharyngeal sample within 24h of surgery, are at low risk of being infected. Instructions for personal protection include specific wound dressings and decontamination of all material used. The operating room should be ventilated after each tracheostomy and the pressure of the room should be neutral or negative. Percutaneous tracheostomy is to be preferred over surgical cervicotomy in order to reduce aerosolization and to avoid moving patients from the intensive care unit to the operating room. Ventilation must be optimized during the procedure, to limit patient oxygen desaturation. Drug assisted neuromuscular blockage is advised to reduce coughing during tracheostomy tube insertion. An experienced team is mandatory to secure and accelerate the procedure as well as to reduce risk of contamination.


Subject(s)
Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Tracheostomy/methods , Tracheostomy/standards , Betacoronavirus/isolation & purification , COVID-19 , Consensus , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/surgery , France/epidemiology , Humans , Infection Control/methods , Infection Control/standards , Intubation, Intratracheal/instrumentation , Intubation, Intratracheal/methods , Intubation, Intratracheal/standards , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/surgery , Postoperative Care/methods , Postoperative Care/standards , SARS-CoV-2 , Ventilation/methods , Ventilation/standards
9.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(3): 177-181, 2020 May.
Article in English | MEDLINE | ID: covidwho-72291

ABSTRACT

OBJECTIVE: Joint guidelines of the French Pediatric Otolaryngology Society (AFOP) and of the French Society of otorhinolaryngology-head and neck surgery (SFORL) on the management of paediatric otolaryngology patients in the context of the COVID-19 pandemic. METHODS: A nation-wide workgroup drew guidelines based on clinical experience, national and local recommendations and scientific literature. Proposals may have to be updated on a day-to-day basis. RESULTS: In children, incidence of symptomatic COVID-19 (1-5%) is low and of good prognosis. The indications for nasal flexible endoscopy should be drastically limited. If undertaken, full Personal Protective Equipment (PPE) including FFP2 masks are required, as well as use of a sheath. Saline nose wash done by caregivers other than parents at home should require PPE. Unless foreign body tracheobronchial aspiration is clinically obvious, CT-scan should be performed to confirm indication of endoscopy. Surgical indications should be limited to emergencies and to cases that cannot be delayed beyond 2 months (especially endonasal, endopharyngeal laryngo-tracheobronchial procedures). Postponement should ideally be a group decision and recorded as such in the medical file. Surgical techniques should be adapted to limit the risk of viral dissemination in the air, avoiding the use of drills, microdebriders, monopolar cautery or lasers. Continuous suction should be placed near the operating field. In case of confirmed Covid-19 cases, or suspected cases (or in some centres systematically), PPE with FFP2 mask should be worn by all staff members present in the operating room.


Subject(s)
Coronavirus Infections/prevention & control , Otolaryngology/methods , Otolaryngology/standards , Pandemics/prevention & control , Pediatrics/methods , Pediatrics/standards , Pneumonia, Viral/prevention & control , Betacoronavirus/isolation & purification , COVID-19 , Child , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Coronavirus Infections/virology , France/epidemiology , Humans , Infection Control/methods , Infection Control/standards , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2
10.
Eur Ann Otorhinolaryngol Head Neck Dis ; 137(3): 159-160, 2020 May.
Article in English | MEDLINE | ID: covidwho-47756

ABSTRACT

In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).


Subject(s)
Coronavirus Infections/prevention & control , Head and Neck Neoplasms/surgery , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Surgical Oncology/methods , Surgical Oncology/standards , Betacoronavirus/isolation & purification , COVID-19 , Consensus , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , France/epidemiology , Head and Neck Neoplasms/virology , Humans , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , SARS-CoV-2 , Squamous Cell Carcinoma of Head and Neck/surgery , Squamous Cell Carcinoma of Head and Neck/virology , Tracheostomy/methods , Tracheostomy/standards
11.
Non-conventional in English | WHO COVID | ID: covidwho-737643

ABSTRACT

The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments.

12.
Non-conventional in English | WHO COVID | ID: covidwho-102218

ABSTRACT

RESUME En ORL, l’examen clinique et les gestes invasifs sur les voies respiratoires et leurs annexes exposent à la transmission directe du SARS-CoV-2 par inhalation ou projection oculaire de gouttelettes contaminées, ou indirecte manuportée ou par l’intermédiaire d’objets ou de surfaces contaminés. L’estimation d’un R0 de la Covid-19 à environ 3 a justifié de reporter les rendez-vous des consultations présentielles non urgentes et de développer la téléconsultation afin de limiter les risques d'infection par le SARS-CoV-2 des patients ou des agents de santé et de participer au respect du confinement. L’autorité sanitaire a recommandé de déprogrammer toute activité ORL chirurgicale ou médicale non urgente et sans préjudice de perte de chance pour les patients. Cette déprogrammation a eu pour objectif d’augmenter très significativement la capacité de soins critiques, prioriser l’accueil de malades de patients Covid-19, prioriser l’affectation des personnels et la mise à disposition des matériels nécessaires à leur fonctionnement, contribuer à la fluidité de l’aval des soins critiques au sein de leur établissement. Il s’agissait également de ne pas exposer les malades concernés à un risque d’exposition infectieuse. Cet article propose des orientations concernant les indications et modalités de réalisation de la chirurgie ORL et la gestion des reports d’intervention dans le contexte pandémique actuel. Il ne s’agit que de conseils de bonne pratique qui doivent naturellement être modulés dans chaque région en fonction de l’évolution de l’épidémie et des organisations préexistantes, et ce dans le cadre de concertations entre les équipes ORL, les unités opérationnelles d’hygiène et toutes les autres spécialités concernées.

SELECTION OF CITATIONS
SEARCH DETAIL